<SEC-DOCUMENT>0001367644-23-000144.txt : 20230731
<SEC-HEADER>0001367644-23-000144.hdr.sgml : 20230731
<ACCEPTANCE-DATETIME>20230731162610
ACCESSION NUMBER:		0001367644-23-000144
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230731
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230731
DATE AS OF CHANGE:		20230731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emergent BioSolutions Inc.
		CENTRAL INDEX KEY:			0001367644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				141902018
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33137
		FILM NUMBER:		231127700

	BUSINESS ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
		BUSINESS PHONE:		240-631-3200

	MAIL ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ebs-20230731.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:b537750d-43c8-4432-8858-0979f04104c5,g:743c719c-1b42-4be8-9efc-ce1078fefc69,d:a7ba97f88cf84cadaeb542c8fae7e822--><html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ebs-20230731</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001367644</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-24">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ebs-20230731.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-31</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia7ba97f88cf84cadaeb542c8fae7e822_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">July 31, 2023</ix:nonNumeric></ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-4">EMERGENT BIOSOLUTIONS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.655%"><tr><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-33137</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-7">14-1902018</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">400 Professional Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-9">Suite 400</ix:nonNumeric>,</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Gaithersburg</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">20879</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">240</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">631-3200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160; Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:10pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.109%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-19">Common Stock, Par Value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-20">EBS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in&#160;Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-22">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 Other Events.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2023, Emergent BioSolutions Inc. (the &#8220;Company&#8221;) issued a press release announcing that the Company was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority for advanced development, manufacturing scale-up, and procurement of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Ansuvimab-zykl) treatment for Ebola. The contract consists of a base period of performance with two option periods valued at approximately $121 million, and five option periods for procurement of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over five years valued at up to $583 million. If all option periods are exercised, the total contract value will be valued at up to approximately $704 million.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergent is responsible for the manufacturing, sale, and distribution of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and Canada pursuant to a collaboration agreement with Ridgeback Biotherapeutics, the developer of the treatment.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Company&#8217;s press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#8239; Financial Statements and Exhibits</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (d)         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.090%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-ebangapr.htm">Press release issued by Emergent BioSolutions Inc. on Ju</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-ebangapr.htm">ly </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-ebangapr.htm">31</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-ebangapr.htm">, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-ebangapr.htm">2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-ebangapr.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.655%"><tr><td style="width:1.0%"></td><td style="width:50.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EMERGENT BIOSOLUTIONS INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: July 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ RICHARD S. LINDAHL</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:  Richard S. Lindahl<br/>Title:  Executive Vice President, Chief Financial<br/>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Officer and Treasurer</span></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a072023-ebangapr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia9710960f08841f9b256cc6def6e9782_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="image.jpg" src="image.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Investor Contact&#58;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Robert G. Burrows</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Vice President, Investor Relations</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">240-631-3280</font></div><div style="text-align:right"><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">burrowsr&#64;ebsi.com</font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Media Contact&#58;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Matt Hartwig </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Senior Director, Media Relations </font></div><div style="text-align:right"><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">mediarelations&#64;ebsi.com</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga&#8482; Treatment for Ebola </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GAITHERSBURG, Md., July 31, 2023</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#8211; Emergent BioSolutions Inc. (NYSE&#58; EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), valued at up to a maximum of $704 million, for advanced development, manufacturing scale-up, and procurement of Ebanga&#8482; (ansuvimab-zykl), a licensed treatment for Ebola virus disease (EVD).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;For almost 25 years, Emergent has tackled the most serious diseases to assist governments in their preparedness and response strategies,&#8221; said Dr. Kelly Warfield, senior vice president, science and development at Emergent. &#8220;Ebola virus has the ability to emerge unexpectedly posing a risk to global health. Its elusive nature makes it difficult to predict when and where an outbreak may occur, which underscores the importance of preparedness efforts against this public health threat.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Emergent is proud to continue providing solutions to and partnering with the U.S. government to strengthen the medical countermeasure infrastructure that enables the development, manufacture, and delivery of essential treatments for deadly diseases,&#8221; said Paul Williams, senior vice president, products business. &#8220;We look forward to collaborating with BARDA and executing on this long-term partnership to expand response planning for Ebola.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 10-year contract consists of a base period of performance with two option periods for advanced development valued at approximately $121 million, and option periods for procurement of Ebanga&#8482; treatment over five years valued at up to $583 million. If all option periods are exercised, the total contract value will be valued at up to approximately $704 million.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the terms of the contract, Emergent will complete activities to advance the development of Ebanga&#8482; treatment through post-licensure commitments, including the transfer of technology as part of manufacturing scale-up, submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration (FDA), and completion of stability studies.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This project has been funded in whole or in part with federal funds from HHS&#59; ASPR&#59; BARDA, under contract number 75A50123C00037. </font></div><div><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="image.jpg" src="image.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Ebanga&#8482; Treatment</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ebanga&#8482; (ansuvimab-zykl) treatment, formerly referred to as mAb114, is a monoclonal antibody with antiviral activity provided through a single infusion and was developed for the treatment of Ebola by Ridgeback Biotherapeutics (Ridgeback Bio) under a license from the National Institute of Allergy and Infectious Diseases. Ridgeback Bio provided funding and operational support for clinical testing, with additional funding received from BARDA, under contract numbers 75A50119C00059 and 75A50120C00009, for late-stage manufacturing and regulatory activities related to FDA approval of Ebanga&#8482; treatment. Ebanga&#8482; treatment was approved by the FDA in December 2020 for the treatment of Ebola.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please see Full Prescribing Information for Ebanga&#8482; (ansuvimab-zykl) </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">here.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2022, Emergent and Ridgeback Bio entered into a collaboration, whereby Emergent is responsible for the manufacturing, sale, and distribution of Ebanga&#8482; treatment in the U.S. and Canada, and Ridgeback Bio serves as the Global Access Partner for Ebanga&#8482; treatment, ensuring it remains available to patients in endemic countries free of charge through Ridgeback Bio&#8217;s compassionate use program. Ridgeback&#8217;s access program provides medical staffing and logistical support, in addition to free medicine, so that patients receive treatment in a timely way.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Ebola Virus Disease</font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ebola virus disease (EVD) is severe and often fatal, with case fatality rates ranging from 25% to 90%, and is transmitted via bodily fluids, zoonotic transmission, or contact with contaminated surfaces. The U.S. Department of Homeland Security has determined that EVD poses a material threat to national health security. To augment the U.S. government&#8217;s response capabilities, BARDA is pursuing advanced development, licensure, and procurement of therapeutics that can be deployed in outbreaks. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Emergent BioSolutions</font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> At Emergent, our mission is to protect and enhance life. For over 20 years, we&#8217;ve been at work defending people from things we hope will never happen&#8212;so we are prepared, just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">website</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and follow us on </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LinkedIn</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Twitter</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Instagram</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Safe Harbor Statement</font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including statements regarding the agreement with BARDA for the advanced development, manufacturing scale-up, and procurement of Ebanga&#8482; treatment, including the potential exercise of option periods and any payments in connection therewith, are forward-looking statements. We generally identify forward-looking statements by using words like &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on Emergent&#8217;s current intentions, beliefs, and expectations regarding future events. Emergent cannot guarantee that any forward-looking statement will be accurate. Readers should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from Emergent&#8217;s expectations. Readers are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, Emergent does not undertake to update any forward-looking statement to reflect new information, events or circumstances. There are a number of important factors that could cause Emergent&#8217;s actual results to differ </font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="image.jpg" src="image.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">materially from those indicated by any forward-looking statements. Readers should consider this cautionary statement, as well as the risk factors identified in Emergent&#8217;s periodic reports filed with the U.S. Securities and Exchange Commission when evaluating Emergent&#8217;s forward-looking statements.</font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ebs-20230731.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:b537750d-43c8-4432-8858-0979f04104c5,g:743c719c-1b42-4be8-9efc-ce1078fefc69-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ebs="http://emergentbiosolutions.com/20230731" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://emergentbiosolutions.com/20230731">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230731_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230731_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPageCoverPage" roleURI="http://emergentbiosolutions.com/role/CoverPageCoverPage">
        <link:definition>0000001 - Document - Cover Page Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ebs-20230731_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:b537750d-43c8-4432-8858-0979f04104c5,g:743c719c-1b42-4be8-9efc-ce1078fefc69-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_8b037dbf-277c-43fb-a820-24cb2026b308_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e8c9de99-8077-4587-9ccb-7c781edf9585_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c6f40b43-3aff-44e5-a9ed-ed2827a42aee_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_820ef4f0-54c8-4599-b7c6-21663f87e318_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_46c3e939-1956-436c-ad05-b2bad34db697_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8441d145-3866-4760-bcf1-9fa7742df4d5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_cb285d3b-63cc-4678-881f-e676c851d3cd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c3e8bea2-fb7d-40a8-9045-81742bf065a7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1c68e93c-0611-45cb-b33f-00c813234bf3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a1c7d53b-9927-4de9-8da1-1b330f89a556_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_93fd8a07-0183-44b5-8b57-8b8bdbdcf6fb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_09b988f8-bcc8-4977-ac6f-17e08fbb8602_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c96690d7-f8cb-499c-a0af-3e068f194ce6_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_347274aa-bc1f-4ed8-9604-977bbac83fa6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c52802db-00c9-4397-81a9-dd7885c3dfdf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_69c5e8b7-eaee-42ae-ad20-ba862f10e16f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f45d068b-8c8f-432c-a95b-dfc9fbd316ca_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e95b63cc-3711-46b0-a492-2fe15a098f2f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_05f59591-eeba-4216-82c3-fbbdcfe850fc_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_01161dc5-0d39-48e4-a74b-84d4c3b97d89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_cf9c2ac9-d0f8-4e4c-90db-007a2c7c24bb_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_051a49f8-74a0-4088-9dcf-9fa5700c38ef_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_f968e35a-a1eb-4824-9b24-c5b0ace9b3cc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bea81a9c-d16f-42ca-a40d-a0c951b75201_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ebs-20230731_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:b537750d-43c8-4432-8858-0979f04104c5,g:743c719c-1b42-4be8-9efc-ce1078fefc69-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CoverPageCoverPage" xlink:type="simple" xlink:href="ebs-20230731.xsd#CoverPageCoverPage"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CoverPageCoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4b1f65ff-ea6a-4473-b72f-17da372d53d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_DocumentType_4b1f65ff-ea6a-4473-b72f-17da372d53d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c194f29b-585a-42c9-8884-b64fc248f1cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_DocumentPeriodEndDate_c194f29b-585a-42c9-8884-b64fc248f1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2543e65c-e3c7-4e1d-a27c-0fabccf57977" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityRegistrantName_2543e65c-e3c7-4e1d-a27c-0fabccf57977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_53d90715-563c-4694-bf70-0300c859f666" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_53d90715-563c-4694-bf70-0300c859f666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_80beac8b-026d-43df-abd1-80c3c57c0130" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityFileNumber_80beac8b-026d-43df-abd1-80c3c57c0130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1a214758-4a43-49cf-b4e7-e6a12d742a2e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityTaxIdentificationNumber_1a214758-4a43-49cf-b4e7-e6a12d742a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_07586414-8358-4b51-a36f-eede10200cf6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityAddressAddressLine1_07586414-8358-4b51-a36f-eede10200cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_164afc16-e8e1-46c2-a50b-d67ef0725955" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityAddressAddressLine2_164afc16-e8e1-46c2-a50b-d67ef0725955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_541c0abc-790b-4217-afa5-f562e78b3a80" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityAddressCityOrTown_541c0abc-790b-4217-afa5-f562e78b3a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_421a43a5-0f6f-49c2-9c91-b42c66c2e774" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityAddressStateOrProvince_421a43a5-0f6f-49c2-9c91-b42c66c2e774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e57a0871-3f21-4b05-84bb-154364bff092" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityAddressPostalZipCode_e57a0871-3f21-4b05-84bb-154364bff092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c5919bc2-cc4b-4f79-aa23-33e5c24f3869" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_CityAreaCode_c5919bc2-cc4b-4f79-aa23-33e5c24f3869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3062b045-0096-4737-961f-70c8d45a79bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_LocalPhoneNumber_3062b045-0096-4737-961f-70c8d45a79bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5841fe3b-550c-4982-8153-c4846d7b4c39" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_WrittenCommunications_5841fe3b-550c-4982-8153-c4846d7b4c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_fed0ce37-94c9-4ebd-abf0-4763f281c96a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_SolicitingMaterial_fed0ce37-94c9-4ebd-abf0-4763f281c96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_dd20a97f-0914-466b-b58b-7ec001faae7a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_PreCommencementTenderOffer_dd20a97f-0914-466b-b58b-7ec001faae7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_091b5547-82d3-4883-b138-17ac782e9170" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_091b5547-82d3-4883-b138-17ac782e9170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_00c24af7-a851-45b3-9476-4040f156514d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityEmergingGrowthCompany_00c24af7-a851-45b3-9476-4040f156514d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b61f1b52-a680-4cfd-ad42-bad1cbd3cc57" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_Security12bTitle_b61f1b52-a680-4cfd-ad42-bad1cbd3cc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6498ca46-b837-47de-aea7-3e53e9613e74" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_TradingSymbol_6498ca46-b837-47de-aea7-3e53e9613e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f28bb66a-a401-4fb6-b5db-6148104f509a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_SecurityExchangeName_f28bb66a-a401-4fb6-b5db-6148104f509a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4e5e5efd-1127-4900-a188-f7a75c4dc1ea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_EntityCentralIndexKey_4e5e5efd-1127-4900-a188-f7a75c4dc1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2e961f97-d8db-45bf-8158-3b2648b1763b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d71baec-9265-40dd-9daa-9b01e309cbe9" xlink:to="loc_dei_AmendmentFlag_2e961f97-d8db-45bf-8158-3b2648b1763b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
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MUZY=0U:M7*G?@TMGS\B6;X;+U#H/J;>_7\R2JYCOS AMS<"N<N'D[QHGD&H
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M/Z.R++YFAHS,9M:O*+NFC\_P-0/41<4*Y?3&#KSEB906-ZR0_=V>_93#+V2
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MS9 Y36K(Q,?S91$S'&?Q-6-#^MF#>V,>E5G<L$+&OKA$PU4 $(N0V;@L'+.
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3-((HALK-I     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140276870235840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page Cover Page<br></strong></div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 31,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EMERGENT BIOSOLUTIONS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">14-1902018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">400 Professional Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Gaithersburg<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-3200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EBS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001367644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ebs-20230731_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ebs-20230731.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2023-07-31</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001367644</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-07-31</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-07-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-4">EMERGENT BIOSOLUTIONS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-33137</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-7">14-1902018</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">400 Professional Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-9">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Gaithersburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">20879</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">631-3200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-19">Common Stock, Par Value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-20">EBS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-21">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M8ED(6[7G*#H2/UROE:SV?A>WZF_(9DH50-8*B,NV 7JUX7LG&?XT97)MXOD
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M='@//GL?)=-[*CG_5U/\!%!+ P04    " !$@_]6EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( $2#_U;E:(KL.0$
M #("   /    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^PEFE#&J*\@+8A
M31L:$^^A=:E%$E>."QM?/[=5!=)>]F3[;%WN+O,S\7%/=$R^O0LQ-[5(,TO3
M6-3@;;RC!H)N*F)O14<^I+%AL&6L <2[]#[+IJFW&,QB/G)M.+T=2* 0I*!@
M!^P0SO&Z[\;DA!'WZ%!^<M/W#DSB,:#'"Y2YR4P2:SJ_$N.%@EBW+9B<R\UD
M6.R !8L_\+83^67WL4?$[C^M"LG--%/""CE*?]'S6]5X CT>IE;H&9T KZS
M"U/;8#AT-.HBO;'1YS#6(<09_R=&JBHL8$5%ZR'(D".#ZP2&6&,331*LA]PL
MZ02<;.P!DFO;^=,'U^7@553D37(\0UWPNASDCAI+J#! ^:ZT47'-J]APTI6>
MY_[A<?*DN;3.+17["&]DR]'R^%V+7U!+ P04    " !$@_]6)!Z;HJT   #X
M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $2#_U9O/W*#[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $2#
M_U:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ 1(/_5NJ5&1UI!   -Q$  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $2#
M_U:?H!OPL0(  .(,   -              "  :P,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ 1(/_5I>*NQS     $P(   L              ( !B \
M %]R96QS+RYR96QS4$L! A0#%     @ 1(/_5N5HBNPY 0  ,@(   \
M         ( !<1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( $2#_U8D
M'INBK0   /@!   :              "  =<1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( $2#_U9ED'F2&0$  ,\#   3
M      "  ;P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
'  84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ebs-20230731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CoverPageCoverPage</Role>
      <ShortName>Cover Page Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ebs-20230731.htm">ebs-20230731.htm</File>
    <File>a072023-ebangapr.htm</File>
    <File>ebs-20230731.xsd</File>
    <File>ebs-20230731_lab.xml</File>
    <File>ebs-20230731_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ebs-20230731.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ebs-20230731.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ebs-20230731_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ebs-20230731_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ebs-20230731.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ebs",
   "nsuri": "http://emergentbiosolutions.com/20230731",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230731.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://emergentbiosolutions.com/role/CoverPageCoverPage",
     "shortName": "Cover Page Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230731.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001367644-23-000144-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001367644-23-000144-xbrl.zip
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MSUUOP(;4X*%4-/38S.QSO30^V.^IJ1W+L!S#=J930].OZ['%M].F,#Y?/2-
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MC%GWE3-(JC@RY#YIW)H):ANF"QSGF^F"@V5JN_?$*L)MZ)5+DB]ME0U@P;$
MHEQ8<&&D8]Z19+H5T#W=D,.;A;B.@Y/[29"\>JY@@I/K6Z)0HD+ #=X(=L\E
M](-E3$,/I8-Z'I;S8V.\.,BGPI?)5IR_.N#.<A%'=!IUSZY/DVR;6=FME$ZE
M9E,I65;4[U>?O _[?O7)^PP[O/IDX0*G.$J4=DVP@&+YW=*53H\@:MBLQR[4
M!5!&:KG+MVZ!2OX.IH(:TSXS7,'H5X/VP&&JT>"!3F0N_X+73WU_&[VZ/JJM
MV)!43 BI;[0CW,)SZM+<PFK,!%&_CZ3BO<F>W(V;D,P=.#\AVO'"784//.JB
MK.@]A7;HF>0(S376R#G66>J1Z2?[[!B\?SD"DT_!^F.=*(@FH^!OT# $!\%#
M!T$-J-(&/^U*'L!%P3-]ONYG6_HPO/8,\7XQ]'"P-8 Q9.CT!*3AW^/EA#[I
M, E-/71.?'+)[ED0Q7HGI#%2@PCC.NW)T*R]_]CD!!RF<-2#"2 ^0+<%!F;&
M*#[18X'K G%#LJL"[DG+!<>$OLA>SZE9+&_ H16+'76*43"+E67_ .]BQ!%R
M];NKO=8<'35".;KG0^H:?TR^!L?@:C*J-%F1,2TW"JA)[H"]4W;#!PG.JRXQ
MI@0QR9Q2K#EF0GO^6,B7W%WZ$)$HGG%=);G'7!=(DDK*U,8<JP1 M'^R'9L
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MFH*L>_HNLXTN.CN<6#*?_"ZL_BW9^O\#4$L#!!0    ( $2#_U;$C5 M?0(
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M6#-C)?JMT3LIO=WC:/+>&E!=T]L-[85\FGU7^3N^*'(FBBE#(I:AZ0(H]6.
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MWIN_ ?S^SP]GBQ\;=[T)=;<X2<%TP2]NRNYRT5V&Q6]-^J/\9!;GE>EBDS8
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M-S(P,C,M96)A;F=A<'(N:'1M4$L! A0#%     @ 1(/_5AZ^IF*$$   1GD
M !               ( !"@\  &5B<RTR,#(S,#<S,2YH=&U02P$"% ,4
M" !$@_]6Q(U0+7T"  "O!P  $               @ &\'P  96)S+3(P,C,P
M-S,Q+GAS9%!+ 0(4 Q0    ( $2#_U:(B]R>L H  $1B   4
M  "  6<B  !E8G,M,C R,S W,S%?;&%B+GAM;%!+ 0(4 Q0    ( $2#_U:=
MOC[WY 8  "XS   4              "  4DM  !E8G,M,C R,S W,S%?<')E
:+GAM;%!+!08     !0 % $(!  !?-      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
